Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Predictors of failure of endoscopic retrograde cholangiopancreatography in clearing bile duct stones during index procedure.

HIGHLIGHTS

  • Failure to clear bile duct stones in the index ERCP can be seen in 15–20% of cases, and identifying the factors associated with failure is important.
  • A prospective analysis was conducted to identify and analyze the factors that could predict the failure of complete CBD clearance.
  • The present study reported a successful clearance of CBD stones during the index procedure in only 70% of patients.
  • A stone diameter ≥15 mm, location of stones in hepatic ducts, presence of stricture distal to stone, and impacted stone were independent predictors of failed bile duct clearance.

 

ABSTRACT – Background –

Common bile duct (CBD) stones are known to complicate 10–15% of gallstone diseases. Endoscopic retrograde cholangiopancreatography (ERCP) is the therapeutic modality of choice for bile duct clearance in CBD stones but may fail to achieve stone clearance. Objective – This prospective study was done to identify the predictors of failure of CBD clearance with ERCP. Methods – All consecutive patients with bile duct stones undergoing ERCP at a tertiary care center were prospectively included from October 2020 to October 2021. The study’s primary outcome was to identify and analyze factors that could predict the failure of complete CBD clearance. Results – A total of 120 patients (50.8% males, median age: 53.5 years) were included in the final analysis. Successful clearance of CBD stones during the index procedure was achieved in 70% of patients. At a cut-off stone diameter of >10.5 mm and CBD diameter of >12.5 mm, the AUC was 0.890 and 0.884, respectively, to predict failed clearance of CBD. On multivariate analysis, stone diameter ≥15 mm [odds ratio (OR) 16.97, 95% confidence interval (CI): 1.629–176.785], location of stones in hepatic ducts (OR 7.74, 95%CI: 2.041–29.332), presence of stricture distal to stone (OR 6.99, 95%CI: 1.402–34.726) and impacted stone (OR 21.61, 95%CI: 1.84–253.058) were independent predictors of failed bile duct clearance. Conclusion – Stone size and location are independent predictors of failed bile duct clearance. The endoscopist should consider these factors while subjecting a patient to biliary ductal clearance to plan additional intervention.

 

AUTORES

Abhishek KAMUNI, Lohith KUMAR, Suprabhat GIRI, Sumaswi ANGADI,  Sunil Kumar NANJEGOWDA and Sukanya BHRUGUMALLA.